Robert Barrow

Insider Reports History

Reporting-owner location: New York, NY
Latest reporting-owner signature: /s/ Mark Sullivan, Attorney-in-Fact for Robert Barrow
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Robert Barrow

Form 4 holding Chief Executive Officer, Director

Definium Therapeutics, Inc.

Security class: Common Shares
Shares / value: 2,213,090
Estimated value: $80,932,701
Report date: 25 Sep 2026
Price: $36.57
Ownership: Direct

Insider Reports Filed by Robert Barrow

4 DFTX

Definium Therapeutics, Inc.

Report period: 25 Sep 2026
Transactions: 1
Transaction value: -$1,153,784
Accepted by SEC: 29 Sep 2026, 21:14
Role: Chief Executive Officer, Director
Next action: Open filing details

4 DFTX

Definium Therapeutics, Inc.

Report period: 14 Sep 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 14 Sep 2026, 08:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 DFTX

Definium Therapeutics, Inc.

Report period: 02 Sep 2026
Transactions: 2
Transaction value: -$721,733
Accepted by SEC: 04 Sep 2026, 21:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 DFTX

Definium Therapeutics, Inc.

Report period: 12 Aug 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 12 Aug 2026, 08:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 DFTX

Definium Therapeutics, Inc.

Report period: 25 Jun 2026
Transactions: 1
Transaction value: -$1,315,236
Accepted by SEC: 26 Jun 2026, 16:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 DFTX

Definium Therapeutics, Inc.

Report period: 22 Jun 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 22 Jun 2026, 09:45
Role: Chief Executive Officer, Director
Next action: Open filing details

4 DFTX

Definium Therapeutics, Inc.

Report period: 25 Mar 2026
Transactions: 1
Transaction value: -$451,241
Accepted by SEC: 26 Mar 2026, 18:42
Role: Chief Executive Officer, Director
Next action: Open filing details

4 DFTX

Definium Therapeutics, Inc.

Report period: 03 Feb 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Feb 2026, 16:53
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 26 Dec 2025
Transactions: 1
Transaction value: -$339,072
Accepted by SEC: 29 Dec 2025, 17:00
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 25 Sep 2025
Transactions: 1
Transaction value: -$252,037
Accepted by SEC: 26 Sep 2025, 17:35
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 25 Jun 2025
Transactions: 1
Transaction value: -$180,139
Accepted by SEC: 26 Jun 2025, 16:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 25 Mar 2025
Transactions: 1
Transaction value: -$142,942
Accepted by SEC: 26 Mar 2025, 17:00
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 12 Mar 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 13 Mar 2025, 16:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 26 Dec 2024
Transactions: 1
Transaction value: -$141,958
Accepted by SEC: 27 Dec 2024, 16:31
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 25 Sep 2024
Transactions: 1
Transaction value: -$118,231
Accepted by SEC: 25 Sep 2024, 20:29
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 19 Aug 2024
Transactions: 2
Transaction value: +$6,215
Accepted by SEC: 20 Aug 2024, 21:14
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 25 Jun 2024
Transactions: 1
Transaction value: -$113,058
Accepted by SEC: 25 Jun 2024, 19:00
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 25 Mar 2024
Transactions: 1
Transaction value: -$156,930
Accepted by SEC: 26 Mar 2024, 17:15
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 27 Feb 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 29 Feb 2024, 16:45
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 26 Dec 2023
Transactions: 1
Transaction value: -$48,050
Accepted by SEC: 26 Dec 2023, 16:50
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 25 Sep 2023
Transactions: 2
Transaction value: -$48,274
Accepted by SEC: 25 Sep 2023, 21:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 27 Jun 2023
Transactions: 2
Transaction value: -$49,620
Accepted by SEC: 27 Jun 2023, 19:41
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 14 Mar 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 17 Mar 2023, 18:41
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 01 Mar 2023
Transactions: 1
Transaction value: -$29,038
Accepted by SEC: 02 Mar 2023, 20:43
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 21 Dec 2022
Transactions: 1
Transaction value: -$10,386
Accepted by SEC: 22 Dec 2022, 15:37
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 25 Oct 2022
Transactions: 1
Transaction value: -$3,392
Accepted by SEC: 25 Oct 2022, 17:57
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 18 Oct 2022
Transactions: 1
Transaction value: -$3,794
Accepted by SEC: 18 Oct 2022, 16:34
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 26 Sep 2022
Transactions: 1
Transaction value: -$6,965
Accepted by SEC: 27 Sep 2022, 18:39
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 16 Sep 2022
Transactions: 1
Transaction value: -$9,801
Accepted by SEC: 19 Sep 2022, 12:58
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 31 Aug 2022
Transactions: 1
Transaction value: -$14,331
Accepted by SEC: 01 Sep 2022, 12:16
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 16 Aug 2022
Transactions: 1
Transaction value: -$13,838
Accepted by SEC: 17 Aug 2022, 18:36
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 25 Jul 2022
Transactions: 1
Transaction value: -$12,890
Accepted by SEC: 26 Jul 2022, 13:23
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 18 Jul 2022
Transactions: 1
Transaction value: -$13,572
Accepted by SEC: 18 Jul 2022, 18:35
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 27 Jun 2022
Transactions: 1
Transaction value: -$25,733
Accepted by SEC: 28 Jun 2022, 18:05
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 16 Jun 2022
Transactions: 1
Transaction value: -$14,892
Accepted by SEC: 21 Jun 2022, 17:12
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 25 May 2022
Transactions: 1
Transaction value: -$14,180
Accepted by SEC: 26 May 2022, 21:09
Role: Chief Executive Officer, Director
Next action: Open filing details

4/A MNMD

Mind Medicine (MindMed) Inc.

Report period: 18 May 2022
Transactions: 1
Transaction value: -$13,453
Accepted by SEC: 19 May 2022, 16:16
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 15 May 2022
Transactions: 1
Transaction value: -$15,537
Accepted by SEC: 17 May 2022, 21:34
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 18 Apr 2022
Transactions: 1
Transaction value: -$17,581
Accepted by SEC: 19 Apr 2022, 19:18
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 15 Mar 2022
Transactions: 1
Transaction value: -$12,612
Accepted by SEC: 17 Mar 2022, 19:26
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 15 Feb 2022
Transactions: 1
Transaction value: -$25,291
Accepted by SEC: 17 Feb 2022, 20:16
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 15 Jan 2022
Transactions: 1
Transaction value: -$199,801
Accepted by SEC: 19 Jan 2022, 18:14
Role: Chief Executive Officer, Director
Next action: Open filing details

3 MNMD

Mind Medicine (MindMed) Inc.

Report period: 01 Jan 2022
Transactions: 0
Transaction value: $0
Accepted by SEC: 10 Jan 2022, 20:26
Role: Chief Executive Officer, Director
Next action: Open filing details

4 MNMD

Mind Medicine (MindMed) Inc.

Report period: 24 Mar 2004
Transactions: 2
Transaction value: $0
Accepted by SEC: 28 Mar 2022, 20:03
Role: Chief Executive Officer, Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .